The Safety of Probiotics: Considerations following the 2011 U.S. Agency for Health Research and Quality Report-Reference-Cited by-同舟云学术

The Safety of Probiotics: Considerations following the 2011 U.S. Agency for Health Research and Quality Report

Published:2011-09-14 Issue:11 Volume:141 Page:1923-1924
ISSN:0022-3166
Container-title:The Journal of Nutrition
language:en
Short-container-title:

Author:

Wallace Taylor C.¹,MacKay Douglas¹

Affiliation:

1. Council for Responsible Nutrition, Washington, DC

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/jn/article-pdf/141/11/1923/23947686/1923.pdf

Reference4 articles.

1. Hempel S Newberry S Ruelaz A Wang Z Miles JNV Suttorp MJ Johnsen B Shanman R Slusser W Fu N et al Safety of probiotics to reduce risk and prevent or treat disease. Evidence-based practice center under contract no. 11–E007. Rockville (MD). Agency for Healthcare Research and Quality; 2011[cited July 1, 2011;]. Available from:www.ahrq.gov/clinic/tp/probiotictp.htm.

2. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials;Whelan;Am J Clin Nutr.,2010

3. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland;Salminen;Clin Infect Dis.,2002

4. Evidence-based criteria in the nutritional context;Blumberg;Nutr Rev.,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review;Probiotics and Antimicrobial Proteins;2023-06-30

2. Probiotics for the prevention of Hirschsprung-associated enterocolitis;Cochrane Database of Systematic Reviews;2022-04-26

3. Probiotics for the prevention of Hirschsprung-associated enterocolitis;Cochrane Database of Systematic Reviews;2020-08-27

4. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial;Trials;2020-06-30

5. Live Biotherapeutic Products, A Road Map for Safety Assessment;Frontiers in Medicine;2020-06-19